The impact of Human Epidermal growth factor Receptor 2 (HER2) expression by RT-PCR on tumor characteristics and outcome in estrogen receptor (ER) positive, HER2 negative early-stage breast cancer

被引：0
|
作者：
Goldvaser, Hadar
Mutai, Raz
Stemmer, Salomon
Kuchuk, Iryna
Tokar, Margarita
Paluch-Shimon, Shani
Yerushalmi, Rinat
Drumea, Karen
Evron, Ella
Sonnenblick, Amir
Gal-Yam, Einav
Bar Sela, Gil
Shai, Ayelet
Merose, Rotem
Bareket-Samish, Avital
Soussan-Gutman, Lior
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-01-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-01-08
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Impact of immunohistochemistry staining conditions on the incidence of human epidermal growth factor receptor 2 (HER2)-low breast cancer
    Kim, Min Chong
    Kwon, Sun Young
    Jung, Hye Ra
    Bae, Young Kyung
    VIRCHOWS ARCHIV, 2024, : 1117 - 1125
  • [42] A human epidermal growth factor receptor 3 (HER3)-binding nanoparticle targets and kills Herceptin®-resistant human epidermal growth factor receptor 2 (HER2)-positive breast cancer
    Sims, J. D.
    Taguaim, M.
    Hanson, C.
    Cui, X.
    Medina-Kauwe, L. K.
    CANCER RESEARCH, 2013, 73
  • [43] Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 Abundance
    Emde, Anna
    Mahlknecht, Georg
    Maslak, Kerstin
    Ribba, Benjamin
    Sela, Michael
    Possinger, Kurt
    Yarden, Yosef
    TRANSLATIONAL ONCOLOGY, 2011, 4 (05): : 293 - 300
  • [44] Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients
    Asgeirsson, Kristjan S.
    Agrawal, Amit
    Allen, Claire
    Hitch, Anthony
    Ellis, Ian O.
    Chapman, Caroline
    Cheung, Kwok L.
    Robertson, John F. R.
    BREAST CANCER RESEARCH, 2007, 9 (06):
  • [45] Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients
    Kristjan S Asgeirsson
    Amit Agrawal
    Claire Allen
    Anthony Hitch
    Ian O Ellis
    Caroline Chapman
    Kwok L Cheung
    John FR Robertson
    Breast Cancer Research, 9
  • [46] Correlation of human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR) expression as predicted by core biopsy with the immunohistochemical results of surgical breast cancer specimens
    Erggelet, Julian
    Grosse, Regina
    Holzhausen, Hans-Juergen
    Hauptmann, Steffen
    Thomssen, Christoph
    BREAST CARE, 2007, 2 (02) : 94 - 98
  • [47] Discordance in Human Epidermal Growth Factor Receptor 2 (HER2) Phenotype Between Primary Tumor and Circulating Tumor Cells in Women With HER2-Negative Metastatic Breast Cancer
    De Gregorio, Amelie
    Friedl, Thomas W. P.
    Huober, Jens
    Scholz, Christoph
    De Gregorio, Nikolaus
    Rack, Brigitte
    Trapp, Elisabeth
    Alunni-Fabbroni, Marianna
    Riethdorf, Sabine
    Mueller, Volkmar
    Schneeweiss, Andreas
    Pantel, Klaus
    Meier-Stiegen, Franziska
    Jaeger, Bernadette
    Hartkopf, Andreas
    Taran, Florin-Andrei
    Fasching, Peter A.
    Janni, Wolfgang
    Fehm, Tanja
    JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 12
  • [48] Systematic Literature Review of Hormone Receptor (HR) Positive, Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer Patients from India
    Singh, M.
    Pratiksha, K.
    Alam, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S160 - S160
  • [49] Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer
    Eggemann, Holm
    Ignatov, Tanja
    Burger, Elke
    Kantelhardt, Eva Johanna
    Fettke, Franziska
    Thomssen, Christoph
    Costa, Serban Dan
    Ignatov, Atanas
    ENDOCRINE-RELATED CANCER, 2015, 22 (05) : 725 - 733
  • [50] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
12345